Dentsply International Inc. (XRAY) Stake Cut by Ownership Capital B.V.
Ownership Capital B.V. reduced its position in Dentsply International Inc. (NASDAQ:XRAY) by 4.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 535,356 shares of the company’s stock after selling 25,966 shares during the period. Dentsply International comprises approximately 5.3% of Ownership Capital B.V.’s portfolio, making the stock its 10th largest position. Ownership Capital B.V.’s holdings in Dentsply International were worth $33,213,000 at the end of the most recent quarter.
Several other institutional investors also recently made changes to their positions in XRAY. Norges Bank acquired a new stake in Dentsply International during the fourth quarter worth $85,870,000. Chevy Chase Trust Holdings Inc. increased its stake in Dentsply International by 74.2% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 212,862 shares of the company’s stock worth $13,118,000 after buying an additional 90,667 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its stake in Dentsply International by 111.1% in the first quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 55,761 shares of the company’s stock worth $3,437,000 after buying an additional 29,346 shares during the period. Exxonmobil Investment Management Inc. TX increased its stake in Dentsply International by 87.4% in the first quarter. Exxonmobil Investment Management Inc. TX now owns 58,744 shares of the company’s stock worth $3,620,000 after buying an additional 27,394 shares during the period. Finally, Raymond James Trust N.A. increased its stake in Dentsply International by 23.8% in the first quarter. Raymond James Trust N.A. now owns 5,511 shares of the company’s stock worth $339,000 after buying an additional 1,061 shares during the period. 94.58% of the stock is owned by institutional investors.
Dentsply International Inc. (NASDAQ:XRAY) traded up 0.54% on Wednesday, hitting $59.89. 1,487,296 shares of the stock traded hands. The company has a market cap of $13.96 billion, a price-to-earnings ratio of 28.10 and a beta of 1.40. Dentsply International Inc. has a 1-year low of $49.48 and a 1-year high of $65.83. The stock has a 50-day moving average price of $60.83 and a 200 day moving average price of $61.57.
Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, August 5th. The company reported $0.76 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.06. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period last year, the company posted $0.73 EPS. The firm’s quarterly revenue was up 46.4% compared to the same quarter last year. On average, analysts anticipate that Dentsply International Inc. will post $2.76 EPS for the current fiscal year.
A number of equities research analysts recently weighed in on XRAY shares. Credit Suisse Group AG reissued a “buy” rating on shares of Dentsply International in a research note on Sunday, June 5th. Piper Jaffray Cos. reissued a “buy” rating on shares of Dentsply International in a research note on Monday, June 27th. Bank of America Corp. assumed coverage on shares of Dentsply International in a research note on Monday, September 12th. They set a “buy” rating and a $70.00 price target for the company. Jefferies Group reaffirmed a “buy” rating on shares of Dentsply International in a research note on Wednesday, August 17th. Finally, Zacks Investment Research downgraded shares of Dentsply International from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Dentsply International has an average rating of “Buy” and an average price target of $67.00.
In other news, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total value of $305,600.00. Following the sale, the vice president now directly owns 34,370 shares in the company, valued at approximately $2,100,694.40. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the sale, the senior vice president now owns 36,730 shares in the company, valued at $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.
About Dentsply International
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.